Millions of new lockdowns and curfews have been imposed in Argentina from India as the Covid-19 infection has risen again and vaccine rollouts have been hampered by fears of a crisis and side effects.
Maharashtra was the worst affected state in India Vaccination is over As the healthcare system falls victim to contagious weight, which has killed 2.9 million people worldwide.
After watching huge religious festivals, political rallies and cricket matches with spectators, the world’s second most populous country has added more than a million new infections since the end of March.
Every weekend, from Saturday to the end of April, 125 million people in Maharashtra will be confined to their homes without traveling or shopping for food or medicine.
Arrangements were also made to enforce a stay-at-home order for Bogota’s eight million residents as the Colombian capital fights third-wave infections, with seven million curfews already in place across four other major cities.
Argentina entered a night-time curfew on Friday, April 30, running from midnight to 6am every day.
It will be effective in the highest risk areas of the country, mainly in urban centers, where bars and restaurants will close at 11 pm.
Argentina and Colombia have recorded nearly 2.5 million coronavirus cases, with Brazil simply surpassing the number in the region.
All parts of France are involved in some form of restriction, while several states have refused to go along with the proposals in an effort by the German government to control movement and trade.
Now Berlin is changing the rules to centralize power, with nighttime curfews and the possibility of some school closures in particularly harsh areas.
However, some countries were in the process of opening.
Italy will end lockdowns in several other regions from next week by improving Loncardi, the epicenter of its coronavirus epidemic, and infection statistics.
Neighboring Slovenia has announced that it will ease coronavirus restrictions and suspend a six-month curfew starting Monday.
As in India, Europe’s asthma vaccine rollout on Friday faced multiple hurdles as EU regulators said they were reviewing the side effects of Johnson and Johnson’s shots and that France had further restricted the use of its AstraZeneca Jab.
France has repeatedly changed the rules for the AstraZeneca vaccine, first with doubts about its effectiveness, but then with fears that it could be linked to blood clots.
The World Health Organization says there is “insufficient information” to switch between CVV-19 vaccines in doses.
Regarding J&J’s shots, the European Medicines Agency reported that AstraZeneca used the same technology with the vaccine, one of the deadliest – four “severe cases” of abnormal blood clots.
The U.S. Food and Drug Administration said it found no effective link between JAB and clots, but noted that “a few individuals” in the country had clots and low levels of platelets in their blood after receiving the vaccine, and its investigation is ongoing.
Both JABs are approved for use in the EU, but the J&K vaccine has not yet been introduced, and several EU countries have stopped or restricted the use of AstraZeneca.
A spokesman for AstraZeneca said half shipments of its vaccine to the EU would be delayed this week.
In Brazil, the Senate has said it will launch an investigation into the government’s handling of the epidemic, as President Joyce Bolsonaro continues to resist lockdown measures following the death of COVID-19 in a new record.
Yet, on Friday, Rio de Janeiro reversed restrictions on the place for two weeks, reopening restaurants and bars, even though the city’s famous beaches were closed.